Clinical trial Recruiting at 3 sites Phase1; Phase2 Interventional Ages 30 to 85

Wearable in-bed robot to boost early leg and ankle recovery after stroke.

Official title: Facilitating Neuroplastic Changes of Acute Stroke Survivors With Severe Hemiplegia

Run by University of Maryland, Baltimore · NCT06404268 · Data updated 2026-11-12

This trial will test a wearable in-bed robot to help people with a recent unilateral stroke — including those with little or no leg movement — retrain ankle and lower-limb function using passive and active training.

More Stroke trials

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages30 Years to 85 Years
SexAll
Enrollment68 (estimated)
SponsorUniversity of Maryland, Baltimore
Academic / other
Locations3 sites (Baltimore, Maryland and 2 other locations)
StatusRecruiting
StartedJune 1, 2025
Main results expectedAugust 31, 2028
Study endsAugust 31, 2028
Registry record updatedJuly 23, 2026
Trial IDNCT06404268 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 30–85 with a first-time unilateral ischemic or hemorrhagic stroke 24 hours to one month prior who have hemiparesis or hemiplegia, ankle impairment, and Manual Muscle Testing scores of 0–2.

Probably not a fit

Patients who are medically unstable, have severe cardiovascular disease, severe ankle contracture (>15°), significant cognitive impairment or aphasia, active lower-leg wounds, or other conditions that prevent exercise are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 1–2 interventional trial tests a novel wearable rehabilitation robot designed for in‑bed use during the acute post-stroke period. The device provides guided motor relearning through passive stretching, passive and active movement, and game-based active movement training targeting ankle and lower-limb function. Participants are acute first-time unilateral stroke patients enrolled 24 hours after admission up to one month post-stroke, including those with minimal or no voluntary motor output (MMT 0–2). The trial will evaluate safety, feasibility, and early signals of functional recovery during the hospital stay.

Why it matters

Potential benefit: If successful, the device could speed early motor recovery, improve ankle and walking function, and reduce long-term disability.

How similar studies have gone: Robot-assisted and early intensive sensorimotor rehabilitation have shown promise for post-stroke motor gains, but wearable in‑bed devices focused on acutely paralyzed patients remain relatively novel and less well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Acute first time unilateral hemispheric stroke (hemorrhagic or ischemic stroke, 24 hours after admission to 1 month post-stroke at the start of the proposed treatment)
* Hemiplegia or hemiparesis
* 0≤Manual Muscle Testing (MMT)\<=2
* Age 30-85
* Ankle impairments including stiff calf muscles and/or inadequate dorsiflexion

Exclusion Criteria:

* Medically not stable
* Associated acute medical illness that interferes with ability to training and exercise
* No impairment or very mild ankle impairment of ankle
* Severe cardiovascular problems that interfere with ability to perform moderate movement exercises
* Cognitive impairment or aphasia with inability to follow instructions
* Severe pain in legs
* Severe ankle contracture greater than 15° plantar flexion (when pushing ankle to dorsiflexion)
* Pressure ulcer, recent surgical incision or active skin disease with open wounds present below knee

Where it's running

  • University of Maryland Baltimore
    Baltimore, Maryland, United States
    Recruiting
  • Umroi
    Baltimore, Maryland, United States
    Recruiting
  • TIRR Memorial Hermann
    Houston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.